Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus – International Task Force

Kalra, Sanjay; Bahendeka, Silver; Sahay, Rakesh; Ghosh, Sujoy; Md, Fariduddin; Orabi, Abbas; Ramaiya, Kaushik; Al Shammari, Sameer; Shrestha, Dina; Shaikh, Khalid; Abhayaratna, Sachitha; Shrestha, PradeepK; Aravinthan, Mahalingam; Askheta, Mazen; A. Rahim, AlyAhmed; Eliana, Fatimah; Shrestha, H.K.; Chaudhary, Sandeep; Ngugi, Nancy; Claude Mbanya, Jean; Aye, ThanThan; Swe Latt, Tint; Akanov, ZhanayA; Syed, AbbasRaza; Tandon, Nikhil; Unnikrishnan, AG; V. Madhu, S.; Jawa, Ali; Chowdhury, Subhankar; Bajaj, Sarita; Das, AshokKumar

doi:10.4103/ijem.ijem_556_17

Public

Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus – International Task Force

Published in Indian Journal of Endocrinology and Metabolism • Jan 1, 2018

Authors:

Sanjay Kalra

Silver Bahendeka

Rakesh Sahay

Abstract

For decades, sulfonylureas (SUs) have been important drugs in the antidiabetic therapeutic armamentarium. They have been used as monotherapy as well as combination therapy. Focus on newer drugs and concerns about the risk of severe hypoglycemia and weight gain with some SUs have led to discussion on...

Subject

Sulfonylurea

Glimepiride

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!